Depreciation of Centessa Pharmaceuticals plc from 30 Jun 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Centessa Pharmaceuticals plc annual and quarterly Depreciation in USD history and change rate from 30 Jun 2021 to 31 Dec 2024.
  • Centessa Pharmaceuticals plc Depreciation for the quarter ending 31 Mar 2024 was $86,000, a 132% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Depreciation for 2024 was $300,000, unchanged from 2023.
  • Centessa Pharmaceuticals plc annual Depreciation for 2023 was $300,000, a 129% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Centessa Pharmaceuticals plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $300,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $300,000 +$169,000 +129% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $131,000 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY

Centessa Pharmaceuticals plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $86,000 +$49,000 +132% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q1 2023 $37,000 +$9,000 +32% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $28,000 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2021 $15,744 01 Jul 2021 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $5,434 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.